See-Mode applies cutting-edge deep learning and computational modeling techniques on medical images to help doctors predict stroke and decide on the optimal treatment for their patients.
See-Mode’s first product, AVA (Augmented Vascular Analysis) has received regulatory clearance in the US, Singapore, Australia and the EU.
- Headquarters
- Singapore
- Founded
- 2017
- Leaders
- Milad Mohammadzadeh, Sadaf Monajemi
- Initial Funding
- 2020, Series A
- MMV Team
-
Carlos Jo-Loo
Yara Alenazi - Co-investors
- Blackbird, Cocoon Capital, SGInnovate, Entrepreneur First
- Relevant Happenings
- Forbes Asia 100 To Watch
MedTech Startup See-Mode Technologies Announces CE Mark and Australian TGA Approval for AI-powered Ultrasound Analysis Software
MedTech Startup See-Mode Technologies Receives FDA Clearance for AI Software That Automatically Analyses and Reports Vascular Ultrasound Scans
The Digital Health 150: The Top Digital Health Companies Of 2021